CN1097578C - Production process of high-purity creatine and its monohydrate - Google Patents
Production process of high-purity creatine and its monohydrate Download PDFInfo
- Publication number
- CN1097578C CN1097578C CN98110909A CN98110909A CN1097578C CN 1097578 C CN1097578 C CN 1097578C CN 98110909 A CN98110909 A CN 98110909A CN 98110909 A CN98110909 A CN 98110909A CN 1097578 C CN1097578 C CN 1097578C
- Authority
- CN
- China
- Prior art keywords
- creatine
- monohydrate
- solution
- aqueous solution
- methylamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 title claims abstract description 109
- 229960003624 creatine Drugs 0.000 title claims abstract description 53
- 239000006046 creatine Substances 0.000 title claims abstract description 53
- 150000004682 monohydrates Chemical class 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 79
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims abstract description 58
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims abstract description 52
- 239000000243 solution Substances 0.000 claims abstract description 39
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000003756 stirring Methods 0.000 claims abstract description 30
- 108010077895 Sarcosine Proteins 0.000 claims abstract description 29
- 229940043230 sarcosine Drugs 0.000 claims abstract description 26
- 238000006243 chemical reaction Methods 0.000 claims abstract description 23
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 20
- 238000001914 filtration Methods 0.000 claims abstract description 17
- 238000005406 washing Methods 0.000 claims abstract description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000010438 heat treatment Methods 0.000 claims abstract description 9
- 229910021529 ammonia Inorganic materials 0.000 claims abstract description 6
- 239000007864 aqueous solution Substances 0.000 claims description 44
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- MEJYXFHCRXAUIL-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid;hydrate Chemical compound O.NC(=N)N(C)CC(O)=O MEJYXFHCRXAUIL-UHFFFAOYSA-N 0.000 claims description 30
- 229960004826 creatine monohydrate Drugs 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 29
- 239000008367 deionised water Substances 0.000 claims description 24
- 229910021641 deionized water Inorganic materials 0.000 claims description 24
- 229940106681 chloroacetic acid Drugs 0.000 claims description 22
- 235000019658 bitter taste Nutrition 0.000 claims description 16
- 239000012065 filter cake Substances 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 10
- 239000013078 crystal Substances 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 238000001953 recrystallisation Methods 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 5
- 239000006227 byproduct Substances 0.000 claims description 3
- 239000012295 chemical reaction liquid Substances 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 238000007864 suspending Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 abstract description 7
- 235000019345 sodium thiosulphate Nutrition 0.000 abstract description 7
- 239000012043 crude product Substances 0.000 abstract description 5
- 238000009833 condensation Methods 0.000 abstract description 2
- 230000005494 condensation Effects 0.000 abstract description 2
- 239000011259 mixed solution Substances 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 16
- 239000002994 raw material Substances 0.000 description 10
- 239000011734 sodium Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 210000003298 dental enamel Anatomy 0.000 description 4
- -1 inorganic acid salt Chemical class 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000007086 side reaction Methods 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229940048098 sodium sarcosinate Drugs 0.000 description 3
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 230000009615 deamination Effects 0.000 description 2
- 238000006481 deamination reaction Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical compound NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000000643 oven drying Methods 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- LFETXMWECUPHJA-UHFFFAOYSA-N methanamine;hydrate Chemical compound O.NC LFETXMWECUPHJA-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical class O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002235 sarcomere Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to a production process of high-purity creatine and a monohydrate thereof. The water solution of chloracetic acid reacts with the water solution of methylamine to generate sarcosine solution; after removing methylamine through heating for condensation, the sarcosine solution is added with the water solution of cyanamide; ammonia is introduced under the condition of stirring the mixed solution until the pH value is between 9 and 12; the reaction solution automatically warms up to 70 to 80 DEG C and reacts for 0.5 to 1.5 hours; through centrifugal filtration, the crude monohydrated creatine is obtained. The crude product is suspended in the water solution of bitter removing agents, such as sodium thiosulfate, etc. to be stirred and washed for 2 to 4 hours; through centrifugal filtration, cake filtration, washing by ionized water and baking, bitterless monohydrate creatine (the water content is less than or equal to 12%) or anhydrous creatine (the water content is less than or equal to 1%) with high purity (more than 99.5%).
Description
The present invention relates to a process for producing high-purity creatine and its monohydrate.
Creatine, also known as sarcomere, is a component of blood, muscle and fish, has the function of repairing cells, can be used for manufacturing medicaments, can also be used as a supplement for human energy, accelerates the synthesis of human protein, supplements creatine with a proper amount, can increase the strength and tolerance of human bodies and delays the generation of fatigue. Creatine is also a raw material for synthetic perfumes and is used for perfume production. Creatine can be used as food additive for food and beverage production. In the prior art, creatine synthesis by reacting sarcosine with cyanamide has been reported, but this method cannot be developed into an economical creatine production process because sarcosine is expensive and yield of creatine is not ideal.
European patent EP0754679 discloses a method for preparing creatine by reacting a creatine sodium aqueous solution and a cyanamide aqueous solution, wherein the reaction temperature is 20-150 ℃, the pH value is 9-10, the pH value of a reaction solution is adjusted by inorganic acid hydrochloric acid or organic acid sarcosine, acetic acid and formic acid, and the reaction product creatine is cleaned by dechlorinated ion water and recrystallized to obtain anhydrous creatine (the water content is less than or equal to 1 percent) or creatine monohydrate (the water content is less than or equal to 12 percent). The reaction is carried out under the condition of weak alkalinity (pH 9-10), and the pH value of the reaction is adjusted by adding inorganic acid hydrochloric acid or organic acid sarcosine, acetic acid or formic acid because the sarcosine sodium aqueous solution is strong alkalinity. Inorganic acid or organic acid is used for adjusting the pH value, and corresponding inorganic acid salt or organic acid salt impurities are introduced. Furthermore, it is impossible to adjust the strong basicity of the sodium sarcosinate solution with sarcosine, because the sarcosine solution itself is weak basic. In addition, the production cost of creatine by using sodium sarcosinate and cyanamide is higher. Creatine produced from cyanamide has an intolerable bitter taste in mouthfeel due to the fact that while creatine is produced by reaction, cyanide-containing impurities including dicyandiamide are also produced, and the bitter taste is unacceptable and toxic and must be removed. When the creatine is washed by the dechlorinated ion aqueous solution at room temperature, the creatine is difficult to remove the bitter taste at one time, and the creatine product is dissolved and lost greatly after repeated washing, so that the yield is reduced. The hot water recrystallization method is used for debitterizing, the effect is poor, and under the condition that the creatine is heated in a water phase, the obvious deamination phenomenon and side reactions such as dehydration into creatinine are generated, and the product yield is influenced.
The invention aims to provide a production process for preparing high-purity creatine and a monohydrate thereof by directly reacting a sarcosine aqueous solution generated by reacting chloroacetic acid with methylamine in a water phase with a cyanamide aqueous solution, which omits the step of purifying sarcosine or sodium sarcosine and then reacting with cyanamide in the background technology and saves the production cost. The creatine monohydrate is refined and debittered with water solution of debittering agent such as sodium thiosulfate to obtain high purity creatine product capable of being taken orally.
The chemical reaction equation of the invention is as follows:
1、 
the invention is realized by the following steps of the production process of the high-purity creatine and monohydrate thereof (the following aqueous solution concentrations are all in percentage by weight):
a. reacting chloroacetic acid aqueous solution with methylamine aqueous solution at 10-30 ℃ to generate sarcosine solution, wherein the reaction time is 8-12 hours;
b. heating at 50-95 ℃ for 1-3 hours to expel methylamine out of the reaction solution;
c. adding sodium hydroxide solution to neutralize and decompose the by-product methylamine chloride in the reaction solution;
d. concentrating under reduced pressure for 1-2 hours at 105-110 ℃ to obtain 30-40% creatine aqueous solution;
e. filtering to remove impurities (precipitates) to obtain a sarcosine aqueous solution, adding the cyanamide aqueous solution into the sarcosine aqueous solution, stirring, introducing ammonia to adjust the pH of the reaction solution to 9-12, and stirring to react at 70-80 ℃ for 0.5-1.0 hour to generate white emulsion creatine;
f. cooling the reaction liquid to 5-15 ℃, stirring for 1-7 hours to generate creatine crystals, centrifugally filtering, leaching a filter cake with deionized water, and spin-drying to obtain crude creatine monohydrate with the purity of 98.5% and the water content of 18%;
g. the coarse creatine monohydrate is treated through suspension, stirring, washing or re-crystallization with deionized water solution of debittering agent to obtain creatine monohydrate with purity over 99.5% and no bitter taste, and the debittering agent may be selected from thiosulfate, sulfite, hypohalite and hypophosphorousacid salt.
The concentration of the methylamine solution is 35-40%, the mol ratio of chloroacetic acid to methylamine is 1: 8-1: 12, preferably 1: 9-1: 10.
The concentration of the sodium hydroxide solution is 30%, and the molar ratio of the sodium hydroxide to the chloroacetic acid is 1.0: 1-1.1: 1.
In the present invention, the mixed solution of the aqueous sarcosine solution and the aqueous cyanamide solution is preferably adjusted to pH9 by adding ammonia.
The concentration of the cyanamide aqueous solution is 25-35%.
The molar ratio of cyanamide to chloroacetic acid is 0.7: 1-1.2: 1, preferably 0.8: 1-1.1: 1.
The concentration of the debitterizing agent aqueous solution is 5-15%.
The suspension stirring washing treatment of the rough creatine monohydrate by the debitterized agent aqueous solution is to suspend the rough creatine monohydrate in the debitterized agent aqueous solution and stir for 2-4 hours, then to carry out centrifugal filtration, to wash out the residual debitterized agent by deionized water from the filter cake, and to dry the filter cake to obtain the creatine monohydrate.
The aqueous solution recrystallization treatment of the debitterized agent for the rough creatine monohydrate is to add deionized water into the rough creatine monohydrate, heat and dissolve the rough creatine monohydrate, add the debitterized agent, stir for 20 to 40 minutes, cool and recrystallize, centrifugally spin-filter, wash out residual debitterized agent by using deionized water in a filter cake, and dry the filter cake to obtain the creatine monohydrate.
The non-bitter creatine monohydrate (the water content is less than or equal to 12%) with the purity of more than 99.5% can be dried to prepare the non-bittercreatine (the water content is less than or equal to 1%).
Dropwise adding chloroacetic acid aqueous solution into methylamine aqueous solution under stirring to react for 8-12 hours, and then carrying out methylamine driving and reduced pressure concentration to obtain aqueous solution containing sarcosine with the concentration of 30-40%. In order to inhibit side reactions from generating di-substituted methyliminodiacetic acid or hydrolyzing the di-substituted methyliminodiacetic acid into glycolic acid, the reaction temperature is required to be as low as possible, the concentration of methylamine is required to be as high as possible, the molar ratio of methylamine to chloroacetic acid is required to be as large as possible, and the reaction temperature is determined to be 10-30 ℃; the concentration of methylamine is within the range of 35-40%, and the molar ratio of methylamine to chloroacetic acid is 8-12, thereby achieving satisfactory results. In order to fully recover methylamine, at the later stage of removing methylamine under normal pressure, sodium hydroxide aqueous solution is dripped to decompose methylamine in byproduct ammonium chloride and remove methylamine. The amount of sodium hydroxide added is such that the substitution is complete and not so much excessive that some of the sodium sarcosinate formed polymerizes at high temperatures. The molar ratio of sodium hydroxide to chloroacetic acid is preferably 1.0: 1 to 1.1: 1. The pH value of the obtained 30-40% sarcosine concentrated solution is below 8. The expelled methylamine is condensed and absorbed by a condenser for recycling.
In the step of reacting an aqueous solution of sarcosine with an aqueous solution of cyanamide, the greater the concentration of the aqueous solution of cyanamide used, the more advantageous the reaction. However, since the price of cyanamide rapidly increases with the increase in concentration and more impurities may be dissolved in a high-concentration cyanamide aqueous solution, it is not always economical to pursue a high concentration, and it is determined that the concentration of the cyanamide aqueous solution is reasonable from 25 to 35%. The molar ratio of the amount of cyanamide to the amount of chloroacetic acid in the reaction is 0.7: 1 to 1.2: 1, preferably 0.8: 1 to 1.1: 1. While the condensation reaction of sarcosine with cyanamide may actually occur, a number of competing side reactions may occur, including the self-polymerization of cyanamide into dicyandiamide and even polymers; cyanamide is hydrated into urea; the polymerization of creatine and the deamination decomposition and dehydration of creatine itself to creatinine. The success of this process is based on the fact that creatine is condensed with cyanamide in the main reaction, which is much faster than the side reactions. In terms of process conditions, the advantages of the main reaction are ensured, the temperature rising speed is high, and the main reaction is completed as soon as possible. The time for keeping at high temperature is short so as to prevent the generated creatine from being further converted and decomposed. Therefore, the reaction and high temperature holding time for automatically raising the temperature to 70 to 80 ℃ is preferably 0.5 to 1.0 hour.
The purity of the crude creatine is about 98.5%, the water content is about 18%, and the creatine has obvious bitter taste. Suspension, stirring, washing or recrystallizing with de-bittering agent solution of deionized water to obtain creatine monohydrate (water content less than or equal to 12%) with purity of 99.5% and no bitter taste, and oven drying to obtain anhydrous creatine (water content less than or equal to 1%).
Compared with the prior art, the invention has the following advantages: firstly, the process of preparing creatine by directly reacting sarcosine solution generated by reacting chloroacetic acid and methylamine in water phase with cyanamide is adopted, so that the production cost is reduced. Secondly, the creatine monohydrate prepared by the process of suspending, stirring and washing crude creatine monohydrate by adopting aqueous solution of debitterizing agent such as sodium thiosulfate and the like or the process of recrystallizing the crude product by using the aqueous solution of the debitterizing agent has no bitter taste. Overcomes the defect that the creatine produced by the reaction of taking cyanamide as a raw material in the prior art has intolerable bitter taste for a long time. The high purity creatine and its monohydrate prepared by the present invention are suitable for all uses including oral administration. Compared with the debitterizing treatment of the crude creatine monohydrate by using the water washing process and the hot water recrystallization process, the process has good debitterizing effect, and the product yield is improved by about 1 time compared with the product yield by using the water recrystallization method.
In order to better practice the invention, the following examples are given to further illustrate the invention, but the examples are not intended to limit the invention.
Example 1
At 1M3700 kg (9kmol) of 40% methylamine aqueous solution is pumped into an enamel reaction kettle with an end face sealed stirring and a high-level dropping storage tank by a material conveying pump. The jacket was cooled with ice brine to below 10 ℃ with stirring. From the head tank, 95 kg (1kmol) of chloroacetic acid was added with 40 kg of dissolved chloroacetic acid in water. Controlling the dropping speed, ensuring the reaction temperature to be 10-30 ℃, standing for 8-12 hours at room temperature after dropping, and transferring into a container with the volume of 1M3Stirring and heating to expel methylamine in an enamel kettle with end face sealed stirring, a high-level sodium hydroxide solution storage tank and a distillation opening connected with a condenser, and heating by adopting a method of gradually raising the temperature: keeping the temperature at 50-60 ℃ for about 1 hour to remove most of methylamine, heating to 95 ℃ to steam methylamine water solution for 1 hour, dropping 140 kg of sodium hydroxide solution (30%), heating to 105 ℃ and concentrating for 1.5 hours. At the moment, the materials in the kettle are concentrated to half of the original volume, and the expelled methylamine is condensed and absorbed by a condenser for recycling. Sucking the concentrated material into 0.5M3With sealed stirring end face, distillation opening and condenser (cooling area 5M)2) Further vacuum concentration in enamel concentration kettle (30 to E)50mbar) to half of the original volume, and carefully filtering the feed liquid in the kettle to remove sodium chloride and iron-containing impurities and precipitate to obtain 250 liters of sarcosine filtrate with the concentration of 30-40%. The filtrate is sucked into an enamel condensation kettle, 130 kg (0.93kmol) of cyanamide aqueous solution with the concentration of 30% is added under stirring, and ammonia is introduced until the pH value is 9, so that the reaction occurs automatically. The temperature rises rapidly and the material is white emulsion due to product precipitation. After 30 minutes the temperature had risen to 75 ℃ at which temperatureKeeping for 30 minutes, injecting cold water into the jacket to cool to 40 ℃, cooling to 15 ℃ by using ice brine, and stirring for 2 hours to ensure that crystallization is complete. Centrifugal filtration, washing the filter cake with deionized water (total washing water amount is 60 kg), and drying to obtain crude creatine monohydrate 110 kg with water content of 18%, purity 98.5% (HPLC), and heavy bitter taste. It was suspended in sodium thiosulfate (Na)2S2O3·10H2O)64 kg of deionized water, 350 kg of deionized water, stirring for 3 hours at room temperature, and centrifuging and filtering. The filter cake was rinsed with deionized water (total water usage 60 kg). 78 kg of white fine crystals with the water content of 18 percent are obtained after spin-drying, and the white fine crystals are dried until the monohydrate (the water content is 11 percent) weighs 72.5 kg, the purity is 99.8 percent (HPLC), the product has no bitter taste, and the yield is 48.7 percent (calculated according to chloroacetic acid).
Product analysis: purity 99.8% (HPLC)
Heavy metal (calculated as iron) is less than or equal to 10ppm
Not detected arsenic
Non-detection of cyano group
The water content is 11%
0.01 percent of ignition residue
Example 2
The amounts of the raw materials, the steps and the products were the same as in example 1, except that the amounts of the raw materials and the yields of the products were different from those in example 1.
Raw materials: 850 kg (11kmol) of 40% methylamine aqueous solution and 170 kg (1.2kmol) of 30% cyanamide aqueous solution.
The product is as follows: the crude creatine monohydrate preparation, containing 18% water, was obtained in the amount of 121 kg (purity 98.5%), which was suspended in sodium thiosulfate (Na)2S2O3·10H2O)128 kg of deionized water and 350 kg of deionized water, stirring for 3 hours at room temperature, and centrifuging and filtering. The filter cake was rinsed with deionized water (total water usage 60 kg). 86 kg of white fine crystals with the water content of 18 percent are obtained after spin-drying, and the white fine crystals are dried until the weight of the monohydrate (the water content is 11 percent) is 79.9 kg and the purity is 99.8 percent (HPLC) without bitter taste. The yield was 53.6% (calculated as chloroacetic acid).
The product analysis was the same as in example 1.
Example 3
The amounts of the raw materials, the steps and the products were the same as in example 1, except that the amounts of the raw materials and the yields of the products were different from those in example 1.
Raw materials: 620 kg (8kmol) of 40% methylamine aqueous solution and 98 kg (0.7kmol) of 30% cyanamide aqueous solution.
The product is as follows: the crude creatine monohydrate preparation, containing 18% water, was obtained in the form of 105 kg (purity 98.5%), which was suspended in sodium thiosulfate (Na)2S2O3·10H2O)43 kg of deionized water 350 kg, stirring for 3 hours at room temperature, and centrifuging and filtering. The filter cake was rinsed with deionized water (total water usage 60 kg). Drying to obtain 74.8 kg of white fine crystals with the water content of 18 percent, and drying until the monohydrate (the water content is 11 percent) weighs 69.5 kg and the purity is 99.8 percent (HPLC) without bitter taste. The yield was 46.6% (calculated as chloroacetic acid).
The product analysis was the same as in example 1.
Example 4
The raw material amount, procedure and crude product yield were the same as in example 1. The same procedure as in example 1 was followed to obtain 110 kg (98.5% purity, 18% water content) of the crude creatine, which was dissolved in 6 times the amount of deionized water, followed by addition of sodium thiosulfate (Na)2S2O3·10H2O) stirring 30 kg for 20 min, filtering while the solution is hot, cooling the filtrate to below 15 ℃, stirring for 4 h, centrifuging, filtering, leaching the filter cake with deionized water (50 kg of total water content)63 kg of white fine grains (water content 18%) without bitter taste, 58 kg of creatine monohydrate (purity 99.7%, water content 11%) and yield 38.3% (calculated on chloroacetic acid) are obtained by drying.
Comparative example 1
The raw material amount, procedure and crude product yield were the same as in example 1. 110 kg of creatine crude product (purity 98.5% and water content 18%) is obtained by the same process as in example 1, 6 times of deionized water is added for heating and dissolving, the solution is filtered while hot, the filtrate is cooled to below 15 ℃, the solution is stirred for 4 hours and centrifuged, the filtrate is filtered, and filter cakes (total washing amount is 30 kg) are leached by deionized water to obtain 70 kg of white crystals (water content 18%) with slight bitterness. Recrystallizing with 6 times of water by the same method to obtain 48 kg (water content 18%) without bitter taste, and oven drying to obtain 33 kg of creatine monohydrate (water content 11%, purity 99.8%) with yield of only 22.1% (calculated on chloroacetic acid).
Claims (10)
1. A process for producing high-purity creatine and its monohydrate, in which the aqueous solution concentration is weight percent, is characterized by that:
a. reacting chloroacetic acid aqueous solution with methylamine aqueous solution at 10-30 ℃ to generate sarcosine solution, wherein the reaction time is 8-12 hours,
b. heating at 50-95 deg.c for 1-3 hr to eliminate methylamine from the reaction liquid,
c. adding sodium hydroxide solution to neutralize and decompose the by-product methylamine chloride in the reaction solution,
d. concentrating under reduced pressure for 1-2 hours at 105-110 ℃ to obtain a sarcosine aqueous solution with the concentration of 30-40%,
e. filtering to remove impurity precipitate, adding cyanamide aqueous solution into the obtained sarcosine aqueous solution, introducing ammonia to adjust the pH of the solution to 9-12 under stirring, reacting for 0.5-1.0 hour under stirring at 70-80 ℃ to generate white emulsion creatine,
f. cooling the reaction liquid to 5-15 ℃, stirring for 1-7 hours to generate creatine crystals, centrifugally filtering, leaching filter cakes with deionized water, spin-drying to obtain crude creatine monohydrate with the purity of 98.5% and the water content of 18%,
g. the coarse creatine monohydrate is treated by suspension, stirring, washing or recrystallization with deionized water solution of debittering agent to obtain creatine monohydrate with purity over 99.5% and no bitter taste, and the water content is less than or equal to 12%.
2. The process for producing high purity creatine and monohydrate thereof according to claim 1, wherein the concentration of the methylamine solution is 35 to 40%, and the molar ratio of chloroacetic acid to methylamine is 1: 8 to 1: 12.
3. The process for producing high purity creatine and monohydrate thereof according to claim 1, wherein the concentration of the sodium hydroxide solution is 30% and the molar ratio of sodium hydroxide to chloroacetic acid is 1.0: 1 to 1.1: 1.
4. The process for producing high purity creatine and monohydrate thereof according to claim 1, wherein the mixture of aqueous sarcosine solution and aqueous cyanamide solution is adjusted to pH9 by adding ammonia.
5. The process for producing high purity creatine and monohydrate thereof according to claim 1, wherein the concentration of the aqueous solution of cyanamide is 25 to 35%.
6. The process for producing high purity creatine and monohydrate thereof according to claim 1, wherein the molar ratio of cyanamide to chloroacetic acid is 0.7: 1 to 1.2: 1.
7. The process for producing high purity creatine and monohydrate thereof according to claim 1, wherein the concentration of the aqueous solution of the debittering agent is 5-15%.
8. The process for producing high purity creatine and its monohydrate according to claim 1, wherein the suspension stirring washing treatment of the creatine monohydrate is prepared by suspending the creatine monohydrate in the aqueous solution of debittering agent, stirring for 2-4 hours, centrifugal filtration, washing off the residual debittering agent from the filter cake with deionized water, and drying.
9. The process for producing high purity creatine and its monohydrate according to claim 1, wherein the said process for recrystallizing creatine monohydrate is carried out by dissolving creatine monohydrate in deionized water under heating, adding debitterizing agent, stirring for 20-40 min, cooling, recrystallizing, centrifugal filtering, washing filter cake with deionized water to remove residual debitterizing agent, and drying.
10. The process for producing a high purity creatine and monohydrate thereof according to claim 1, 7, 8 or 9, wherein the non-bitter creatine monohydrate having a purity of 99.5% or more and a water content of 12% or less is dried to produce a non-aqueous creatine having a water content of 1% or less.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98110909A CN1097578C (en) | 1998-06-19 | 1998-06-19 | Production process of high-purity creatine and its monohydrate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98110909A CN1097578C (en) | 1998-06-19 | 1998-06-19 | Production process of high-purity creatine and its monohydrate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1240207A CN1240207A (en) | 2000-01-05 |
| CN1097578C true CN1097578C (en) | 2003-01-01 |
Family
ID=5220924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98110909A Expired - Fee Related CN1097578C (en) | 1998-06-19 | 1998-06-19 | Production process of high-purity creatine and its monohydrate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1097578C (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101239924B (en) * | 2008-02-29 | 2011-05-04 | 浙江大学 | Method for preparing functionality amino acid |
| CN103922952A (en) * | 2014-05-07 | 2014-07-16 | 宁夏宝马药业有限公司 | Method for preparing cyclopropylglycine by using hydroxyacetonitrile |
| CN105418462A (en) * | 2015-12-28 | 2016-03-23 | 江苏远洋药业股份有限公司 | Synthetic method of creatine |
| CN107721882A (en) * | 2016-08-11 | 2018-02-23 | 宁夏天成生化科技有限公司 | Preparation method of N-methyl guanidino propionic acid |
| CN106831495A (en) * | 2016-12-28 | 2017-06-13 | 安徽省虹升生物股份有限公司 | A kind of chemical industry synthesis method of creatine monohydrate |
| CN113603618B (en) * | 2021-07-13 | 2023-06-09 | 无锡贝塔医药科技有限公司 | Preparation method of creatine-D3 |
| CN114591203B (en) * | 2022-02-15 | 2024-03-29 | 上海奥萝拉医药科技有限公司 | Preparation method of high-purity creatine |
| CN115260047B (en) * | 2022-06-14 | 2024-07-12 | 太仓市新毛涤纶化工有限公司 | Preparation method of creatine monohydrate |
| CN115636772B (en) * | 2022-10-25 | 2024-05-10 | 安徽泰格生物科技有限公司 | Preparation method of high-purity creatine monohydrate |
| CN115772100B (en) * | 2022-12-16 | 2024-06-11 | 山东阳谷华泰化工股份有限公司 | Method for continuously producing creatine monohydrate by micro-channel reaction device |
| CN116041226B (en) * | 2022-12-16 | 2024-06-11 | 山东阳谷华泰化工股份有限公司 | Method for continuously synthesizing creatine monohydrate |
| CN116924942A (en) * | 2023-05-19 | 2023-10-24 | 山东凯密斯新材料科技有限公司 | Creatine synthesis method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0754679A1 (en) * | 1995-07-18 | 1997-01-22 | SKW Trostberg Aktiengesellschaft | Process for the preparation of creatin or creatine-monohydrate |
-
1998
- 1998-06-19 CN CN98110909A patent/CN1097578C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0754679A1 (en) * | 1995-07-18 | 1997-01-22 | SKW Trostberg Aktiengesellschaft | Process for the preparation of creatin or creatine-monohydrate |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1240207A (en) | 2000-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1097578C (en) | Production process of high-purity creatine and its monohydrate | |
| US8217197B2 (en) | Process for producing methionine | |
| US8101797B2 (en) | Process for producing methionine | |
| US4310690A (en) | Preparation of the calcium salt of α-hydroxy-gamma-methylmercaptobutyric acid | |
| CN1168701C (en) | Method for purifying branched chain amino acids | |
| US6472380B1 (en) | Glucosamine sulfate calcium chloride composition and processes for the preparation of glucosamine sulfate metal chlorides | |
| CN114591203A (en) | Preparation method of high-purity creatine | |
| JPH08333312A (en) | Purification of valine | |
| CZ20032548A3 (en) | Purification process of 2-nitro-4-methylsulfonylbenzoic acid | |
| CN115636772B (en) | Preparation method of high-purity creatine monohydrate | |
| CN1234596C (en) | Process for preparing fluorine compound and SiO2 from sodium fluosilicate | |
| EP4271666B1 (en) | Process for the diastereomerically pure preparation of dl/ld-methionylmethionine | |
| CN104355990A (en) | Method for recycling and mechanically using L- (+) -tartaric acid in D-ethyl ester production | |
| JPS60217897A (en) | Method for separating and purifying lactic acid | |
| EP0526854A2 (en) | Method for recovery of alpha-L-aspartyl-L-phenylalanine methyl ester, L-phenylalanine and l-aspartic acid | |
| CN1154654C (en) | Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline | |
| EP0564775A2 (en) | Process for pharmaceutical grade high purity iodeoxycholic acid preparation | |
| EP1603863B1 (en) | Process for the preparation of amino methyl cyclo alkane acetic acids | |
| JP2001247529A (en) | Method for producing α-amino acid amide | |
| CN1100753C (en) | Process for preparing crystal 0-methyl-isourea acetate | |
| JP2942380B2 (en) | Method for purifying methacrylamide | |
| KR820001129B1 (en) | Method for recovery of l-glutamic acid from fermentation broth | |
| CN115819259A (en) | A kind of method for preparing sarcosine by chelating calcium | |
| CN104326901A (en) | Method for recycling and mechanically using L- (+) -tartaric acid in D-ethyl ester production | |
| CN119661443A (en) | Co-production recovery process of 5-ethyl hydantoin and hydrochloride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |